[131I]MIBG as a first line treatment in advanced neuroblastoma.

The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR)

Volumn 39, Issue 4 Suppl 1, 1995, Pages 61-64

  Hoefnagel, C A ^a   De Kraker, J ^a   Valdes Olmos R A ^a   Voute P A ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; ANTINEOPLASTIC AGENT; IODOBENZENE; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ARTICLE; CHILD; DRUG RESISTANCE; FEASIBILITY STUDY; FEMALE; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIMAL RESIDUAL DISEASE; MULTIMODALITY CANCER THERAPY; NEUROBLASTOMA; PATHOLOGY; POSTOPERATIVE CARE; PRESCHOOL CHILD; REMISSION;

3-IODOBENZYLGUANIDINE; ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DRUG RESISTANCE, NEOPLASM; FEASIBILITY STUDIES; FEMALE; HUMANS; INFANT; INJECTIONS, INTRAVENOUS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; NEOPLASM, RESIDUAL; NEUROBLASTOMA; POSTOPERATIVE CARE; RADIOPHARMACEUTICALS; REMISSION INDUCTION;

EID: 0029422472     PISSN: 11250135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)